Combination chemotherapy associated with improved survival in refractory colorectal cancer [RECOURSE]
1. TAS-102 is a combination of a thymidine-based nucleic acid analogue, trifluridine, and a thymidine phosphorylase inhibitor, tipiracil hydrochloride. 2. ...







![Triple-combo chemotherapy improves survival for metastatic colon cancer [TRIBE study]](https://www.2minutemedicine.com/wp-content/uploads/2014/10/640px-Cyclophosphamide_iv-350x250.jpg)
